• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐匿性输卵管癌引发的遗传性乳腺癌和卵巢癌:一例报告。

Hereditary breast and ovarian cancer triggered by occult fallopian tube cancer: a case report.

机构信息

Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki, Osaka, 569-8686, Japan.

Department of Pathology, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki, Osaka, 569-8686, Japan.

出版信息

J Med Case Rep. 2023 Aug 18;17(1):351. doi: 10.1186/s13256-023-04095-6.

DOI:10.1186/s13256-023-04095-6
PMID:37592269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10436669/
Abstract

BACKGROUND

At the time of benign gynecological surgery, a prophylactic salpingo-oophorectomy or salpingectomy is increasingly being performed concurrently to reduce the risk of future ovarian and fallopian tube cancer. We herein describe a case of hereditary breast and ovarian cancer syndrome in which a hysterectomy and bilateral adnexectomy were performed with a preoperative diagnosis of benign tumor. A detailed pathological examination revealed occult fallopian tube cancer, and additional staging surgery provided an accurate pathology diagnosis.

CASE PRESENTATION

A 72-year-old Japanese woman with a past history of breast cancer underwent a hysterectomy and bilateral oophoro-salpingectomy for the preoperative diagnosis of uterine myoma and a right para-ovarian cyst. In the detailed pathological examination, high-grade serous carcinoma of the right fallopian tube was detected incidentally, and a subsequent staging laparotomy confirmed single para-aortic lymph node metastasis. Furthermore, a mutation in germline BRCA2 was detected postoperatively, and the patient was finally diagnosed with hereditary breast and ovarian cancer syndrome. She was diagnosed with fallopian tube cancer International Federation of Gynecology and Obstetrics Stage IIIA1(i) and started on adjuvant therapy (six courses of paclitaxel and carboplatin followed by maintenance therapy with olaparib), and 18 months after surgery, she was free of disease.

CONCLUSION

This is a case of fallopian tube cancer that was diagnosed incidentally and then accurately staged with additional advanced staging surgery. Even in the absence of grossly malignant findings, a detailed pathological search of the fallopian tubes and accurate staging surgery are important to make the necessary treatment decisions for the patient.

摘要

背景

在进行良性妇科手术时,越来越多地同时进行预防性输卵管卵巢切除术或输卵管切除术,以降低未来卵巢和输卵管癌的风险。本文描述了一例遗传性乳腺癌和卵巢癌综合征病例,该患者术前诊断为良性肿瘤,行子宫切除术和双侧附件切除术。详细的病理检查显示隐匿性输卵管癌,并进行了进一步的分期手术以提供准确的病理诊断。

病例介绍

一名 72 岁日本女性,既往有乳腺癌病史,因术前诊断为子宫肌瘤和右侧附件囊肿而行子宫切除术和双侧卵巢输卵管切除术。在详细的病理检查中,意外发现右侧输卵管高级别浆液性腺癌,随后进行分期剖腹手术证实存在单一腹膜后淋巴结转移。此外,术后检测到胚系 BRCA2 突变,最终诊断为遗传性乳腺癌和卵巢癌综合征。患者被诊断为输卵管癌国际妇产科联合会(FIGO)分期 IIIA1(i),开始接受辅助治疗(紫杉醇和卡铂 6 个疗程,随后奥拉帕利维持治疗),术后 18 个月,患者无疾病。

结论

这是一例偶然诊断出的输卵管癌,然后通过进一步的高级别分期手术进行了准确分期。即使没有明显的恶性发现,对输卵管进行详细的病理检查和准确的分期手术对于为患者做出必要的治疗决策非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a115/10436669/2e80fa08f7d9/13256_2023_4095_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a115/10436669/e777f07257f5/13256_2023_4095_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a115/10436669/228828dad4ff/13256_2023_4095_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a115/10436669/9482821ec218/13256_2023_4095_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a115/10436669/2e80fa08f7d9/13256_2023_4095_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a115/10436669/e777f07257f5/13256_2023_4095_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a115/10436669/228828dad4ff/13256_2023_4095_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a115/10436669/9482821ec218/13256_2023_4095_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a115/10436669/2e80fa08f7d9/13256_2023_4095_Fig4_HTML.jpg

相似文献

1
Hereditary breast and ovarian cancer triggered by occult fallopian tube cancer: a case report.隐匿性输卵管癌引发的遗传性乳腺癌和卵巢癌:一例报告。
J Med Case Rep. 2023 Aug 18;17(1):351. doi: 10.1186/s13256-023-04095-6.
2
Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.通过对良性手术中偶然切除的输卵管进行系统检查,可早期发现遗传性乳腺癌和卵巢癌综合征低危女性的高级别输卵管浆液性癌。
Am J Surg Pathol. 2014 Jun;38(6):729-42. doi: 10.1097/PAS.0000000000000199.
3
Value of adjuvant chemotherapy and informed microscopic examination for occult gynecologic cancer detected upon risk-reducing salpingo-oophorectomy after chemotherapy for BRCA1/2-associated breast cancer: a case report.BRCA1/2 相关乳腺癌化疗后行输卵管卵巢切除术时偶然发现隐匿性妇科癌行辅助化疗和知情显微镜检查的价值:病例报告。
Jpn J Clin Oncol. 2021 Mar 3;51(3):492-497. doi: 10.1093/jjco/hyaa239.
4
Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.BRCA 突变女性行降低风险的输卵管卵巢切除术时的卵巢病理学,着重隐匿性原发性癌与转移性癌的鉴别诊断
Am J Surg Pathol. 2009 Aug;33(8):1125-36. doi: 10.1097/PAS.0b013e31819e986a.
5
Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.遗传性乳腺癌和卵巢癌日本女性行预防性输卵管卵巢切除术的临床和病理结局。
Int J Clin Oncol. 2021 Dec;26(12):2331-2337. doi: 10.1007/s10147-021-02020-9. Epub 2021 Aug 28.
6
Serous tubal intraepithelial carcinoma in a Japanese woman with a deleterious BRCA1 mutation.一名携带有害 BRCA1 突变的日本女性发生输卵管浆液性上皮内癌。
Jpn J Clin Oncol. 2014 Jun;44(6):597-601. doi: 10.1093/jjco/hyu035. Epub 2014 Apr 9.
7
High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy.在预防性双侧输卵管卵巢切除术中诊断出的隐匿性输卵管癌发生率较高。
Int J Gynecol Cancer. 2009 Jul;19(5):826-9. doi: 10.1111/IGC.0b013e3181a1b5dc.
8
No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.第344号——普通人群中卵巢/输卵管/腹膜癌的机会性输卵管切除术及其他降低风险方法。
J Obstet Gynaecol Can. 2017 Jun;39(6):480-493. doi: 10.1016/j.jogc.2016.12.005.
9
Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.大多数情况下,偶然发现的非子宫高级别浆液性癌起源于输卵管:高级别浆液性癌起源于输卵管的进一步证据。
Am J Surg Pathol. 2015 Mar;39(3):357-64. doi: 10.1097/PAS.0000000000000353.
10
Management of advanced-stage primary carcinoma of the fallopian tube: case report and literature review.晚期原发性输卵管癌的治疗:病例报告及文献综述
Eur J Gynaecol Oncol. 2003;24(6):557-60.

引用本文的文献

1
Pathology of the Salpinx: A Retrospective Literature Review.输卵管病理学:一项回顾性文献综述
Cureus. 2024 Aug 23;16(8):e67624. doi: 10.7759/cureus.67624. eCollection 2024 Aug.

本文引用的文献

1
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.遗传/家族性高风险评估:乳腺癌、卵巢癌和胰腺癌,第 2.2021 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001.
2
Risk of incidental genital tract malignancies at the time of myomectomy and hysterectomy for benign conditions.因良性疾病行子宫肌瘤切除术和子宫切除术时发生生殖道偶发性恶性肿瘤的风险。
Obstet Gynecol Sci. 2021 Mar;64(2):209-215. doi: 10.5468/ogs.20199. Epub 2020 Dec 16.
3
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
奥拉帕利联合贝伐珠单抗作为卵巢癌一线维持治疗。
N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361.
4
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.尼拉帕利治疗新诊断的晚期卵巢癌患者。
N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28.
5
Pathological findings following risk-reducing salpingo-oophorectomy in BRCA mutation carriers: A systematic review and meta-analysis.BRCA 基因突变携带者预防性输卵管卵巢切除术的病理结果:系统评价和荟萃分析。
Eur J Surg Oncol. 2020 Jan;46(1):139-147. doi: 10.1016/j.ejso.2019.09.002. Epub 2019 Sep 5.
6
Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.日本遗传性乳腺癌和卵巢癌患者行预防性输卵管卵巢切除术的临床背景和结局。
Int J Clin Oncol. 2019 Sep;24(9):1105-1110. doi: 10.1007/s10147-019-01456-4. Epub 2019 May 4.
7
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.奥拉帕利维持治疗新诊断的晚期卵巢癌患者。
N Engl J Med. 2018 Dec 27;379(26):2495-2505. doi: 10.1056/NEJMoa1810858. Epub 2018 Oct 21.
8
Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.因良性指征行子宫切除术或子宫肌瘤剔除术的女性隐匿性妇科癌症。
Obstet Gynecol. 2018 Apr;131(4):642-651. doi: 10.1097/AOG.0000000000002521.
9
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌、卵巢癌和对侧乳腺癌风险。
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
10
Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer.在患有良性疾病且卵巢癌风险相对较低的患者切除的输卵管中检测浆液性前驱病变。
Pathol Int. 2016 Jun;66(6):337-42. doi: 10.1111/pin.12419.